Molecule News and Research

RSS

New optical signature in magnetic beads could quickly detect contaminants in diagnostic tests

Getting results from a blood test can take anywhere from one day to a week, depending on what a test is targeting. The same goes for tests of water pollution and food contamination.

25 Aug 2023

Researchers discover new therapeutic approach for neuroblastoma

Neuroblastomas are tumors of the nervous system. They can form in many places in the body and are the most common cause of cancer-related deaths in young children.

25 Aug 2023

Two small molecule inhibitors can help improve precision, efficiency of CRISPR-Cas9 gene editing

A new study published in Nature Communications demonstrates how small molecule inhibitors can be used to improve the precision and efficiency of CRISPR-Cas9 gene editing.

25 Aug 2023

Midnolin protein plays key role in breaking down short-lived nuclear proteins

Short-lived proteins control gene expression in cells to carry out a number of vital tasks, from helping the brain form connections to helping the body mount an immune defense.

24 Aug 2023

Women with pre-eclampsia undergo accelerated aging during pregnancy

Pre-eclampsia, a life-threatening surge in blood pressure, is an enigmatic condition. Each year, it causes the deaths of more than 70,000 women worldwide. Because scientists do not know what causes it, they lack targeted strategies to treat it.

24 Aug 2023

Urine levels of adenine found to be predictive and causative biomarker of diabetic kidney disease

Urine levels of adenine, a metabolite produced in the kidney, are predictive and a causative biomarker of looming progressive kidney failure in patients with diabetes, a finding that could lead to earlier diagnosis and intervention, researchers from The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) reported Aug. 24 in the Journal of Clinical Investigation.

24 Aug 2023

How have inflammatory bowel disease treatments changed after the introduction of biologics?

Researchers compared changes in inflammatory bowel disease treatment strategies before and after the introduction of biologics in Japan.

24 Aug 2023

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

Researchers described the preclinical profile of JT002, a novel and orally bioavailable small molecule inhibitor of the NLRP3 inflammasome.

24 Aug 2023

Study shows how cancer can selfishly hijack a helpful immune pathway to spread

A study led by researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.

23 Aug 2023

UC researchers study parasite that causes Chagas disease

Almost everything about insects called kissing bugs is revolting, from the insidious way they bite people's faces at night to drink their blood while they sleep to the way they spread disease through their poop.

23 Aug 2023

Stowers researchers reveal why certain anti-cancer drugs can cause unexpected side effects

With around 90% of drugs failing to make it to market, the potential for improving efficiency within the drug development industry is clear. Drugs designed to combat cancers suffer similar rates of failure for many reasons.

23 Aug 2023

New kidney tissue model could help assess safety of immunotherapy drugs

A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells.

23 Aug 2023

The gut microbiota associated with prediabetes and treatment naïve type 2 diabetes patients

The gut-inhabiting bacteria in pre-type 2 diabetes (pre-T2D) patients.

23 Aug 2023

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute (THI) a two-year, $1.14 million grant to develop a novel, first-in-class drug to treat cardiovascular disease (CVD) as a significant improvement to current treatment regimens - specifically for adverse events arising from atherosclerosis.

22 Aug 2023

Molecule News and Research

New optical signature in magnetic beads could quickly detect contaminants in diagnostic tests

Researchers discover new therapeutic approach for neuroblastoma

Two small molecule inhibitors can help improve precision, efficiency of CRISPR-Cas9 gene editing

Midnolin protein plays key role in breaking down short-lived nuclear proteins

Women with pre-eclampsia undergo accelerated aging during pregnancy

Urine levels of adenine found to be predictive and causative biomarker of diabetic kidney disease

How have inflammatory bowel disease treatments changed after the introduction of biologics?

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

Study shows how cancer can selfishly hijack a helpful immune pathway to spread

UC researchers study parasite that causes Chagas disease

Stowers researchers reveal why certain anti-cancer drugs can cause unexpected side effects

New kidney tissue model could help assess safety of immunotherapy drugs

The gut microbiota associated with prediabetes and treatment naïve type 2 diabetes patients

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

The growing role of AI in science and discovery

New microneedles could monitor melanoma therapy response

New DNA-based anticoagulant could treat heparin-induced thrombocytopenia

Unleashing the Power of Microfluidic Picodroplets

Glycans and GBPs: How their interplay shapes immunity in infection and autoimmune diseases

Beneficial gut bacteria use mucus lining to stay in place, study finds

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News